Brief: Theriva Biologics Says Data For 9 Evaluable Patients Were Reviewed By Study Monitoring Committee Who Agreed Trial Had Positive Outcome

Theriva Biologics

23/04/2024 12:35

April 23 (Reuters) - Theriva Biologics Inc  TOVX.A :
    * THERIVA BIOLOGICS INC - DATA FOR 9 EVALUABLE PATIENTS WERE
REVIEWED BY STUDY MONITORING COMMITTEE WHO AGREED THAT TRIAL HAD
A POSITIVE OUTCOME
    * THERIVA BIOLOGICS INC - VCN-01 WAS WELL TOLERATED AFTER
INTRAVITREAL ADMINISTRATION AT 2 DOSES
    * THERIVA BIOLOGICS INC - INTRAVITREAL VCN-01 DEMONSTRATED
PROMISING ANTITUMOR ACTIVITY AND DID NOT APPEAR TO CHANGE
RETINAL FUNCTION

Source text for Eikon:  ID:nGNX29BYs5 
Further company coverage:  TOVX.A 

 ((Reuters.Briefs@thomsonreuters.com;))